Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Kabco Pharmaceuticals, Inc.

Kabco Pharmaceuticals, Inc. Recalls

All product recalls associated with Kabco Pharmaceuticals, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

304

Class I (Serious)

34

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 4081–4100 of 4747 recalls

Perfect 3000 Vanilla Powder (Kabco Pharmaceuticals) – Consent Decree Violation (2013)

Firm had distributed the bulk product in violation of the Consent Decree for Permanent Injunction (12-CV-3468).

Class IIModerate

FDAApr 9, 2013NY• Kabco Pharmaceuticals, Inc.

Lorazepam (Legacy) – Labeling Error (2013)

Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009

FDAMar 27, 2013IN• Legacy Pharmaceutical Packaging LLC

Bupropion Hydrochloride Tablets XL (Actavis) – Dissolution Failure (2013)

Failed USP Dissolution Test Requirements: Out-of-specification dissolution results at the 8 hour stability testing point.

1...203 204205206 207...238

Page 205 of 238Next

Low

FDAMar 22, 2013Nationwide• Actavis South Atlantic LLC

Disulfiram Tablets (Teva) – Missing Cotton Coil (2013)

CGMP Deviation; cotton coil is missing in some packaged bottles

FDAMar 19, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Donnatal Extentabs (West-ward) – Incorrect Labeling (2013)

Labeling: Incorrect or Missing Lot and/or Exp Date: Bottled product is labeled with an expiration date of Apr 2015. The correct expiration is Apr 2013.

Class IIModerate

FDAMar 18, 2013Nationwide• West-ward Pharmaceutical Corp.

Ethambutol Tablets (West-ward) – Subpotent Medication (2013)

Subpotent Drug: Out Of Specification results for assay at the stability time-point of 24 months.

Class IIModerate

FDAMar 18, 2013Nationwide• West-ward Pharmaceutical Corp.

Well at Wallgreens Antacid (Tarmac/Axara) – Microbial Contamination (2013)

Microbial Contamination of Non-Sterile Products: Lot in question had an elevated microbial count outside of specifications and E. Coli contamination.

Class IIModerate

FDAMar 16, 2013Nationwide• Tarmac Products, Inc. d.b.a. Axara Pharmaceuticals

Balziva Tablets (Teva) – Impurity Specification Failure (2013)

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

FDAMar 15, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Camila Tablets (Teva) – Impurity Specification Failure (2013)

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

FDAMar 15, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Junel Fe Tablets (Teva) – Impurity Specification Failure (2013)

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

FDAMar 15, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Errin Tablets (Teva) – Impurity Specification Failure (2013)

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

FDAMar 15, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Lessina Tablets (Teva) – Impurity Specification Failure (2013)

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

FDAMar 15, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Jolessa Tablets (Teva) – Impurity Specification Failure (2013)

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

FDAMar 15, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Seasonale Tablets (Teva) – Impurity Specification Failure (2013)

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing

FDAMar 14, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Camrese Tablets (Teva) – Impurity Specification Failure (2013)

Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing

FDAMar 14, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Combat Powder (Integrity Nutraceuticals) – packaging contamination (2013)

One lot of each product may have extraneous materials due to a problem on the packing line.

Class IIModerate

FDAMar 14, 2013AR, CA, CO +11 more• F.H.G Corporation dba Integrity Nutraceuticals

Combat Powder (Musclepharm) – Packaging Contamination (2013)

One lot of each product may have extraneous materials due to a problem on the packing line.

Class IIModerate

FDAMar 14, 2013AR, CA, CO +11 more• F.H.G Corporation dba Integrity Nutraceuticals

Portia Tablets (Teva) – Appearance Specification Failure (2013)

Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.

FDAMar 12, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Jolessa Tablets (Teva) – Appearance Specification Failure (2013)

Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.

FDAMar 12, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Venlafaxine Tablets (Zydus) - Broken Tablet Defect (2013)

Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.

Class IIModerate

FDAMar 5, 2013Nationwide• Zydus Pharmaceuticals USA Inc